Sinofn Health
Sinofn Health
SINOFN Health Co., Ltd., established in 2025 (building on a legacy since 2012), is a national high-tech enterprise backed by the Chinese Academy of Sciences (CAS). We bridge the gap between complex biomedical research and scalable commercial nutraceutical production. As a specialized ODM/OEM partner, we offer more than manufacturing; we offer a strategic R&D pipeline that transforms clinical concepts into market-ready, science-backed supplement products for global brands.
Mrs. GuoHong Liu, driven by clinical experience, pivoted from personal advocacy to systemic health solutions. By focusing on PKU (Phenylketonuria) and FSMP (Foods for Special Medical Purposes), SINOFN has cultivated an R&D-first culture that permeates our entire contract manufacturing business, ensuring every formulation is bio-valid.
Our alliance with the Chinese Academy of Sciences provides our clients with unparalleled access to cutting-edge material science. From high-purity NMN synthesis to advanced bioavailability optimization for plant-based extracts like Tremella Polysaccharide, we operate at the intersection of biotechnology and consumer wellness.
In the current global economic landscape, supply chain stability is the new currency of competitive advantage. SINOFN leverages China's industrial ecosystem efficiency, integrated with advanced digital manufacturing protocols.
Entering the international supplement market requires navigating a labyrinth of regulatory frameworks—FDA, EFSA, NMPA, and TGA. SINOFN provides:
